<?DTDIdentifier.IdentifierValue -//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.1 20151215//EN?>
<?DTDIdentifier.IdentifierType public?>
<?SourceDTD.DTDName JATS-journalpublishing1.dtd?>
<?SourceDTD.Version 1.1?>
<?ConverterInfo.XSLTName jp2nlmx2.xsl?>
<?ConverterInfo.Version 1?>
<?covid-19-tdm?>
<front>
  <journal-meta>
    <journal-id journal-id-type="nlm-ta">Bioinformatics</journal-id>
    <journal-id journal-id-type="iso-abbrev">Bioinformatics</journal-id>
    <journal-id journal-id-type="publisher-id">bioinformatics</journal-id>
    <journal-title-group>
      <journal-title>Bioinformatics</journal-title>
    </journal-title-group>
    <issn pub-type="ppub">1367-4803</issn>
    <issn pub-type="epub">1367-4811</issn>
    <publisher>
      <publisher-name>Oxford University Press</publisher-name>
    </publisher>
  </journal-meta>
  <article-meta>
    <article-id pub-id-type="pmcid">7558925</article-id>
    <article-id pub-id-type="pmid">32805021</article-id>
    <article-id pub-id-type="doi">10.1093/bioinformatics/btaa739</article-id>
    <article-id pub-id-type="publisher-id">btaa739</article-id>
    <article-categories>
      <subj-group subj-group-type="heading">
        <subject>Applications Note</subject>
      </subj-group>
      <subj-group subj-group-type="category-taxonomy-collection">
        <subject>AcademicSubjects/SCI01060</subject>
      </subj-group>
    </article-categories>
    <title-group>
      <article-title>CoV-AbDab: the Coronavirus Antibody Database</article-title>
    </title-group>
    <contrib-group>
      <contrib contrib-type="author">
        <name>
          <surname>Raybould</surname>
          <given-names>Matthew I J</given-names>
        </name>
        <xref ref-type="aff" rid="btaa739-aff1"/>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Kovaltsuk</surname>
          <given-names>Aleksandr</given-names>
        </name>
        <xref ref-type="aff" rid="btaa739-aff1"/>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Marks</surname>
          <given-names>Claire</given-names>
        </name>
        <xref ref-type="aff" rid="btaa739-aff1"/>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Deane</surname>
          <given-names>Charlotte M</given-names>
        </name>
        <xref ref-type="corresp" rid="btaa739-cor1"/>
        <xref ref-type="aff" rid="btaa739-aff1"/>
        <!--<email>deane@stats.ox.ac.uk</email>-->
      </contrib>
    </contrib-group>
    <aff id="btaa739-aff1"><institution>Oxford Protein Informatics Group, Department of Statistics, University of
Oxford</institution>, 24-29 St. Giles’, Oxford, OX1 3LB, <country country="GB">United
Kingdom</country></aff>
    <contrib-group>
      <contrib contrib-type="editor">
        <name>
          <surname>Wren</surname>
          <given-names>Jonathan</given-names>
        </name>
        <role>Associate Editor</role>
      </contrib>
    </contrib-group>
    <author-notes>
      <corresp id="btaa739-cor1">To whom correspondence should be addressed.
<email>deane@stats.ox.ac.uk</email></corresp>
    </author-notes>
    <pub-date pub-type="epub" iso-8601-date="2020-08-17">
      <day>17</day>
      <month>8</month>
      <year>2020</year>
    </pub-date>
    <elocation-id>btaa739</elocation-id>
    <history>
      <date date-type="received">
        <day>25</day>
        <month>6</month>
        <year>2020</year>
      </date>
      <date date-type="rev-recd">
        <day>10</day>
        <month>8</month>
        <year>2020</year>
      </date>
      <date date-type="accepted">
        <day>10</day>
        <month>8</month>
        <year>2020</year>
      </date>
    </history>
    <permissions>
      <copyright-statement>© The Author(s) (2020). Published by Oxford University Press. All
rights reserved. For Permissions, please email:
journals.permissions@oup.com</copyright-statement>
      <copyright-year>2020</copyright-year>
      <license license-type="publisher-standard" xlink:href="https://academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_model">
        <license-p>This article is published and distributed under the terms of the Oxford
University Press, Standard Journals Publication Model (<ext-link ext-link-type="uri" xlink:href="https://academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_model">https://academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_model</ext-link>)</license-p>
      </license>
      <license>
        <license-p>This article is made available via the PMC Open Access Subset for unrestricted re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the COVID-19 pandemic or until permissions are revoked in writing. Upon expiration of these permissions, PMC is granted a perpetual license to make this article available via PMC and Europe PMC, consistent with existing copyright protections.</license-p>
      </license>
    </permissions>
    <self-uri xlink:href="btaa739.pdf"/>
    <abstract>
      <title>Abstract</title>
      <sec id="s1">
        <title>Motivation</title>
        <p>The emergence of a novel strain of betacoronavirus, SARS-CoV-2, has led to a pandemic
that has been associated with over 700,000 deaths as of 5<sup>th</sup> August 2020.
Research is ongoing around the world to create vaccines and therapies to minimise rates
of disease spread and mortality. Crucial to these efforts are molecular
characterisations of neutralising antibodies to SARS-CoV-2. Such antibodies would be
valuable for measuring vaccine efficacy, diagnosing exposure, and developing effective
biotherapeutics. Here, we describe our new database, CoV-AbDab, which already contains
data on over 1400 published/patented antibodies and nanobodies known to bind to at least
one betacoronavirus. This database is the first consolidation of antibodies known to
bind SARS-CoV-2 as well as other betacoronaviruses such as SARS-CoV-1 and MERS-CoV. It
contains relevant metadata including evidence of cross-neutralisation, antibody/nanobody
origin, full variable domain sequence (where available) and germline assignments,
epitope region, links to relevant PDB entries, homology models, and source
literature.</p>
      </sec>
      <sec id="s2">
        <title>Results</title>
        <p>On 5<sup>th</sup> August 2020, CoV-AbDab referenced sequence information on 1402
anti-coronavirus antibodies and nanobodies, spanning 66 papers and 21 patents. Of these,
1131 bind to SARS-CoV-2.</p>
      </sec>
      <sec id="s3">
        <title>Availability</title>
        <p>CoV-AbDab is free to access and download without registration at <ext-link ext-link-type="uri" xlink:href="http://opig.stats.ox.ac.uk/webapps/coronavirus">http://opig.stats.ox.ac.uk/webapps/coronavirus</ext-link>. Community submissions are
encouraged.</p>
      </sec>
      <sec id="s4">
        <title>Supplementary information</title>
        <supplementary-material content-type="local-data" id="sup1">
          <label>btaa739_Supplementary_Data</label>
          <media xlink:href="btaa739_supplementary_data.pdf">
            <caption>
              <p>Click here for additional data file.</p>
            </caption>
          </media>
        </supplementary-material>
        <p>Supplementary data are
available at <italic>Bioinformatics</italic> online.</p>
      </sec>
    </abstract>
    <counts>
      <page-count count="2"/>
    </counts>
    <custom-meta-group>
      <custom-meta>
        <meta-name>edited-state</meta-name>
        <meta-value>accepted-manuscript</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>article-lifecycle</meta-name>
        <meta-value>PAP</meta-value>
      </custom-meta>
    </custom-meta-group>
  </article-meta>
</front>
